Clinical Trial Update: Clinical Correlation Evaluation of the LIVERFASt Test for Diagnosing Important Liver Lesions of Fibrosis and Steatosis Against Magnetic Resonance Elastography (MRE) for Liver Fibrosis and MR-based Assessment of Steatosis, in Adult US Population.

View source ↗

Summary

Clinical trial evaluating the LIVERFASt diagnostic test for diagnosing liver fibrosis and steatosis, using MR elastography as a reference standard, in the adult…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alcohol-related Liver Disease
• Metabolic Dysfunction-associated Steatotic Liver Disease
• Non-alcoholic Steatohepatitis-related Liver Fibrosis

Drugs mentioned

• LIVERFASt test

Snippet

Sponsor: Fibronostics USA, Inc | Conditions: Liver Fibrosis Due to NASH, MASLD - Metabolic Dysfunction-Associated Steatotic Liver Disease | Status: NOT_YET_RECRUITING